The Journal of Molecular Diagnostics: Machine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and Identify Therapeutic Candidates
Quest Diagnostics and NIH/NIAID-funded study demonstrating RNA-seq-based ML classification of NMO vs. MS, with identification of actionable therapeutic targets.
This study aims to identify RNA biomarkers distinguishing neuromyelitis optica (NMO) from relapsing-remitting multiple sclerosis (RRMS) and explore potential therapeutic applications leveraging machine learning.
